Helper function of cytolytic lymphocytes: Switching roles in the immune response

European Journal of Immunology

Volumn 37, Issue 1, 2007, Pages 66-77

  Li Pira, Giuseppina ^a   Ivaldi, Federico ^b   Bottone, Laura ^c   Koopman, Gerrit ^d   Manca, Fabrizio ^b  

^a ADVANCED BIOTECHNOLOGY CENTER   (Italy)

^b G GASLINI INSTITUTE   (Italy)

^c UNIVERSITY OF INSUBRIA   (Italy)

^d BIOMEDICAL PRIMATE RESEARCH CENTRE   (Netherlands)

Author keywords

CMV; CTL; Cytokines; Helper function; T cell lines

Indexed keywords

ANTIGEN; INTERLEUKIN 2; INTERLEUKIN 4; INTERLEUKIN 5; INTERLEUKIN 6;

ARTICLE; B LYMPHOCYTE; CELL GROWTH; CELL ISOLATION; CELL SPECIFICITY; CELLULAR IMMUNITY; CONTROLLED STUDY; CULTURE MEDIUM; CYTOKINE PRODUCTION; CYTOMEGALOVIRUS; CYTOTOXIC T LYMPHOCYTE; HELPER CELL; HUMAN; HUMAN CELL; LYMPHOCYTE FUNCTION; LYMPHOCYTE PROLIFERATION; PERIPHERAL BLOOD MONONUCLEAR CELL; PRIORITY JOURNAL; T LYMPHOCYTE ACTIVATION;

CELL LINE; CYTOMEGALOVIRUS; CYTOMEGALOVIRUS INFECTIONS; GRAFT REJECTION; GRAFT VS HOST DISEASE; HUMANS; IMMUNITY, CELLULAR; IMMUNOPHENOTYPING; T-LYMPHOCYTES, CYTOTOXIC; T-LYMPHOCYTES, HELPER-INDUCER;

EID: 33846344999     PISSN: 00142980     EISSN: None     Source Type: Journal    
DOI: 10.1002/eji.200636337     Document Type: Article

References (35)

1. Davis, M. M. and Bjorkman, P. J., T-cell antigen receptor genes and T-cell recognition. Nature 1988. 334: 395-402.
2. Meuer, S. C., Acuto, O., Hercend, T., Schlossman, S. F. and Reinherz, E. L., The human T-cell receptor. Annu. Rev. Immunol. 1984. 2: 23-50.
3. + T cell responses: the alternative approaches. Annu. Rev. Immunol. 1997. 15: 297-322.
4. + T cell effector mechanisms in resistance to infection. Annu. Rev. Immunol. 2000. 18: 275-308.
5. + T lymphocytes in culture. Nature 1984. 308: 365-367.
6. + cytotoxic T cell clones. A novel potentially immunoregulatory T-T cell interaction in man. J. Exp. Med. 1990. 171: 2011-2024.
7. Sun, Q., Burton, R. L. and Lucas, K. G., Cytokine production and cytolytic mechanism of CD4(+) cytotoxic T lymphocytes in ex vivo expanded therapeutic Epstein-Barr virus-specific T-cell cultures. Blood 2002. 99: 3302-3309.
8. Appay, V., Zaunders, J. J., Papagno, L., Sutton, J., Jaramillo, A., Waters, A., Easterbrook, P. et al., Characterization of CD4(+) CTLs ex vivo. J. Immunol. 2002. 168: 5954-5958.
9. + T cells. J. Exp. Med. 1997 186: 1407-1418.
10. Harari, A., Vallelian, F. and Pantaleo, G., Phenotypic heterogeneity of antigen-specific CD4 T cells under different conditions of antigen persistence and antigen load. Eur. J. Immunol. 2004. 34: 3525-3533.
11. Harari, A., Vallelian, F., Meylan, P. R. and Pantaleo, G., Functional heterogeneity of memory CD4 T cell responses in different conditions of antigen exposure and persistence. J. Immunol. 2005. 174: 1037-1045.
12. Mallard, E., Vernel-Pauillac, F., Velu, T., Lehmann, F., Abastado, J. P., Salcedo, M. and Bercovici, N., IL-2 production by virus- and tumor-specific human CD8 T cells is determined by their fine specificity. J. Immunol. 2004. 172: 3963-3970.
13. Li Pira, G., Bottone, L., Ivaldi, F., Tagliamacco, A., Fiordoro, S., Ricciardi, A., Barbano, G. and Manca, F., Generation of cytomegalovirus (CMV)-specific CD4 T cell lines devoid of alloreactivity by use of a mixture of CMV-phosphoprotein 65 peptides for reconstitution of the T helper repertoire. J. InfeCt. Dis. 2005. 191: 215-226.
14. Li Pira, G., Bottone, L., Ivaldi, F., Del Galdo, F., Papa, F., Accolla, R., Koopman, G. et al., Human naive CD4 T-cell clones specific for HTV envelope persist for years in vivo in the absence of antigenic challenge. J. Acquir. Immune. Defic. Syndr. 2005. 40: 132-139.
15. Carson, R. T. and Vignali, D. A., Simultaneous quantitation of 15 cytokines using a multiplexed flow cytometric assay. J. Immunol. Methods 1999. 227: 41-52.
16. Howard, M. and Paul, W. E., Regulation of B-cell growth and differentiation by soluble factors. Annu. Rev. Immunol. 1983. 1: 307-333.
17. Kishimoto, T., Akira, S. and Taga, T., Interleukin-6 and its receptor: a paradigm for cytokines. Science 1992. 258: 593-597.
18. Lanzavecchia, A., Receptor-mediated antigen uptake and its effect on antigen presentation to class II-restricted T lymphocytes. Annu. Rev. Immunol. 1990. 8: 773-793.
19. Russell, J. H. and Ley, T. J., Lymphocyte-mediated cytotoxicity. Annu. Rev. Immunol. 2002. 20: 323-370.
20. Tanchot, C. and Rocha, B., CD8 and B cell memory: same strategy, same signals. Nat. Immunol. 2003. 4: 431-432.
21. + T cell help. J. Infect. Dis. 2004. 189: 971-983.
22. De Rosa, S. C., Lu, F. X., Yu, J., Perfetto, S. P., Falloon, J., Moser, S., Evans, T. G. et al., Vaccination in humans generates broad T cell cytokine responses. J. Immunol. 2004. 173: 5372-5380.
23. Zimmerli, S. C., Harari, A., Cellerai, C., Vallelian, F., Bart, P. A. and Pantaleo, G., HIV-1-specific IFN-gamma/IL-2-secreting CD8 T cells support CD4-independent proliferation of HIV-1-specific CD8 T cells. Proc. Natl. Acad. Sci. USA 2005. 102: 7239-7244.
24. Trautmann, L., Rimbert, M., Echasserieau, K., Saulquin, X., Neveu, B., Dechanet, J., Cerundolo, V. and Bonneville, M., Selection of T cell clones expressing high-affinity public TCRs within human cytomegalovirus-specific CD8 T cell responses. J. Immunol. 2005. 175: 6123-6132.
25. Wong, P. and Pamer, E. G., CD8 T cell responses to infectious pathogens. Annu. Rev. Immunol. 2003. 21: 29-70.
26. Sun, J. C. and Bevan, M. J., Defective CD8 T cell memory following acute infection without CD4 T cell help. Science 2003. 300: 339-342.
27. Musey, L., Hughes, J., Schacker, T., Shea, T., Corey, L. and McElrath, M. J., Cytotoxic-T-cell responses, viral load, and disease progression in early human immunodeficiency virus type 1 infection. N. Engl. J. Med. 1997 337: 1267-1274.
28. Lane, H. C., Masur, H., Edgar, L. C., Whalen, G., Rook, A. H. and Fauci, A. S., Abnormalities of B-cell activation and immunoregulation in patients with the acquired immunodeficiency syndrome. N. Engl. J. Med. 1983. 309: 453-458.
29. Belshe, R. B., Van Voris, L. P. and Mufson, M. A., Parenteral administration of live respiratory syncytial virus vaccine: results of a field trial. J. Infect. Dis. 1982. 145: 311-319.
30. Varga, S. M., Wang, X., Welsh, R. M. and Braciale, T. J., Immunopathology in RSV infection is mediated by a discrete oligoclonal subset of antigen-specific CD4(+) T cells. Immunity 2001. 15: 637-646.
31. Vessie, E. L., Hirsch, G. M. and Lee, T. D., Aortic allograft vasculopathy is mediated by CD8(+) T cells in cyclosporin A immunosuppressed mice. Transpl. Immunol. 2005. 15: 35-44.
32. van den Elsen, P. J. and Gobin, S. J., The common regulatory pathway of MHC class I and class II transactivation. Microbes Infect 1999. 1: 887-892.
33. Reddy, P. and Ferrara, J. L., Immunobiology of acute graft-versus-host disease. Blood Rev 2003. 17: 187-194.
34. Rocha, P. N., Plumb, T. J., Crowley, S. D. and Coffman, T. M., Effector mechanisms in transplant rejection. Immunol. Rev. 2003. 196: 51-64.
35. Roden, M. M., Lee, K. H., Panelli, M. C. and Marincola, F. M., A novel cytolysis assay using fluorescent labeling and quantitative fluorescent scanning technology. J. Immunol. Methods 1999. 226: 29-41.